BTW - anyone who thinks diarrhoea could be an issue, have a look at this label warning for recently approved Brenzavvy for diabetes
https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214373s000lbl.pdf
- Forums
- ASX - By Stock
- Ann: Rett Syndrome NDA accepted for Priority Review by FDA
BTW - anyone who thinks diarrhoea could be an issue, have a look...
-
- There are more pages in this discussion • 125 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$13.60 |
Change
-0.320(2.30%) |
Mkt cap ! $1.761B |
Open | High | Low | Value | Volume |
$13.94 | $13.96 | $13.50 | $4.840M | 353.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 52 | $13.60 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.61 | 1081 | 21 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 456 | 13.600 |
9 | 1275 | 13.590 |
10 | 1691 | 13.580 |
4 | 532 | 13.570 |
5 | 1225 | 13.560 |
Price($) | Vol. | No. |
---|---|---|
13.610 | 495 | 14 |
13.620 | 546 | 6 |
13.630 | 802 | 6 |
13.640 | 531 | 5 |
13.650 | 3500 | 10 |
Last trade - 15.56pm 06/09/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |